Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.430
-0.010 (-0.69%)
Dec 5, 2025, 4:00 PM EST - Market closed
Standard BioTools Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Standard BioTools stock has a target of 1.35, which predicts a decrease of -5.59% from the current stock price of 1.43.
Analyst Consensus: Hold
* Price targets were last updated on Nov 5, 2025.
Analyst Ratings
The average analyst rating for Standard BioTools stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains $1.55 → $1.35 | Hold | Maintains | $1.55 → $1.35 | -5.59% | Nov 5, 2025 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 27, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $2.75 → $2.5 | Strong Buy | Maintains | $2.75 → $2.5 | +74.83% | Oct 31, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $3.5 → $2.75 | Strong Buy | Maintains | $3.5 → $2.75 | +92.31% | Aug 1, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates $3.5 | Strong Buy | Initiates | $3.5 | +144.76% | Apr 16, 2024 |
Financial Forecast
Revenue This Year
81.15M
from 174.43M
Decreased by -53.48%
Revenue Next Year
80.52M
from 81.15M
Decreased by -0.78%
EPS This Year
-0.26
from -0.52
EPS Next Year
-0.16
from -0.26
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 84.8M | 85.6M | ||
| Avg | 81.2M | 80.5M | ||
| Low | 78.3M | 75.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -51.4% | 5.4% | ||
| Avg | -53.5% | -0.8% | ||
| Low | -55.1% | -6.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.25 | -0.16 | |
| Avg | -0.26 | -0.16 | |
| Low | -0.27 | -0.16 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.